Home ⟩ Insights

Insights

interview

roca pre roll cannabis cones hemp medical marijuana

3 min read • May 28, 2026

ROCA Wants To Be The Infrastructure Behind Cannabis’ Next Product Category

stock stocks markets chart psychedelics cannabis

4 min read • April 28, 2026

Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck

New Jersey Cannabis panel

4 min read • February 26, 2026

Margin Percent Isn’t The Point Anymore: “Dollars In My Pocket” Takes Over

Jason Wild and Tim Seymour

3 min read • February 19, 2026

When Will Marijuana Be Rescheduled? This Cannabis Veteran Says Industry Is ‘Getting Close’

3 min read • December 31, 2025

The Cannabis Retail Advantage Few Are Talking About: Inside A Different Approach

min read • December 4, 2025

Trump-Backed GOP Rep. Randy Fine To Cannabis Leaders: Don’t Assume Congress Understands Cannabis Policy, Focus On ‘Easy Wins’

min read • December 3, 2025

Top Cannabis Execs See New Era For Industry As Rescheduling Optimism Grows

min read • December 2, 2025

With Millions on the Line, This Cannabis Giant’s CEO Says the Industry Finally Has a Clear Path Forward

min read • November 26, 2025

Rescheduling May Be Coming, But State Cannabis Models Matter More Than Ever, CEO Says

min read • November 11, 2025

Can L.A. Save Its Cannabis Market Before It’s Too Late? Inside the City Leaders’ Plan

min read • October 3, 2025

Inside New York’s Cannabis Vape Boom: Trust, Innovation And Consumer Trends

min read • October 2, 2025

Canopy USA Eyes Beverages As Growth Engine Amid Shifting Cannabis Market

Latest Headlines

3 min read • October 16, 2026

Inside Cronos’ 58% Revenue Growth: Market Share and Expansion

3 min read • October 15, 2026

DEA Cannabis Rescheduling Faces New October 21 Deadline After Judge Weighs Reopening Hearing

2 min read • October 15, 2026

Glass House Eyes European Cannabis Exports After GACP Certification

2 min read • October 15, 2026

“Curaleaf’s Revised Offer Still Does Not Reflect the Value”: Aurora Rejects $5 Hostile Bid

6 min read • October 15, 2026

Organigram Wants More Than Revenue From Germany. It Wants the Whole Margin

5 min read • October 14, 2026

The Real Cost of a Cannabis Gummy: Azuca’s CEO on Manufacturing Margins and Scale

5 min read • October 14, 2026

Cannabis Products Have to Earn Their Shelf Space. Curio Wellness Explains How

min read • October 13, 2026

Cronos Has a $1 Billion War Chest. Zuanic Sees Up to 3x Upside

5 min read • October 13, 2026

Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027

4 min read • October 9, 2026

Vireo Secures $60 Million at 8.5% to Refinance Cannabis Facilities in New York and Florida

6 min read • October 9, 2026

“This Defies All Fiduciary Logic”: Curaleaf Fires Back at Aurora; Rival Deal Rumors Swirl

4 min read • October 9, 2026

Aurora Doubles German Cannabis Output, Giving Investors More to Weigh in Curaleaf Takeover

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.

(opens in a new tab)